Article
Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis.
Cancer treatment and research communications - 1 Jan 2021
Yang Shuang, Xia Jun, Yang Zeren, Xu Mingming, Li Shuwei
Abstract excerpt
Lung cancer is the leading cause of mortality and morbidity in tumor-related deaths in the world. Early detection of tumors can greatly improve the survival rate of patients. However, the lack of reliable blood biomarkers remains a major challenge for early diagnosis. The blood proteins secreted by the lung bronchi and bronchial arteries may have characteristic glycosylation patterns associated with tumors, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.